Complementary & Alternative Medicine for Mental Health

(sharon) #1
OUTLINE

EFFICACY

MONOTHERAPY FOR DEPRESSION

ADJUNCTIVE USE FOR DEPRESSION

NEUROPROTECTION

SUGGESTED BUT UNPROVEN USES: ADHD

DRUG INTERACTIONS

SIDE EFFECTS

DOSAGE

RESEARCH


  1. S-adenosyl-L-methionine (commonly called “SAM-e”), a naturally-occurring metabolite
    engaged in over 200 essential chemical reactions within all cells of the body, was discovered
    in 1952. SAM-e is safe both short and long-term because it is a substance that the body
    needs more of as we age or if we get ill. It is more like a vitamin or an amino acid than a
    drug.

  2. It has been approved as a prescription drug for depression in Germany, Italy, Spain and
    Russia, and has been in use in Europe for over three decades. It was released in the United
    States for non-prescription sale in 1999. SAM-e participates in the synthesis of many
    essential molecules, including the neurotransmitters norepinephrine, dopamine and
    serotonin, which are implicated in major depression. SAM-e has an important role in the
    structure of the lipid bilayer in cell membranes, perhaps altering their electrical properties
    to facilitate transmission. This in turn appears to affect mood.

  3. EFFICACY

  4. MONOTHERAPY FOR DEPRESSION

Free download pdf